<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Bile acids synthesis and enterohepatic circulation " Version="20181009" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Bile Acid Synthesis and Enterohepathic Circulation. 
In hepatocytes, cholesterol is acquired through de novo synthesis as well as receptor-mediated endocytosis of cholesterol-rich lipoproteins. Cholesterol is eliminated through bile acid synthesis and secretion. The first (and rate-limiting) step in cholesterol conversion  to bile acids is catalyzed by CYP7A1. Bile acids are then secreted into the bile via ABCB11 and released into the small intestine. The majority of bile acids are re-absorbed into the enterocytes via ASBT and transported back to the liver via portal circulation via NTCP.  In the hepatocyte, bile acids activate FXR, which inhibits CYP7A1. In the small intestine, bile acids also activate FXR to induce FGF15, which subsequently binds and activates FGFR4, leading to inhibition of CYP7A1, partially via ERK signaling.
Based on figure 1 in [https://www.ncbi.nlm.nih.gov/pubmed/29653253 Wang et al].

 </Comment>
  <BiopaxRef>b8e</BiopaxRef>
  <Graphics BoardWidth="824.4796238244518" BoardHeight="593.4796238244514"/>
  <DataNode TextLabel="LDL" GraphId="a1845" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Bile Acid" GraphId="a42f3" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Bile acid" GraphId="a9220" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="MAPK1" GraphId="b3596" Type="GeneProduct" GroupRef="e0e57">
        </DataNode>
  <DataNode TextLabel="FXR1" GraphId="b8394" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="NTCP" GraphId="cbf70" Type="Protein">
        </DataNode>
  <DataNode TextLabel="ABCG8" GraphId="cc25c" Type="GeneProduct" GroupRef="d61c8">
        </DataNode>
  <DataNode TextLabel="LDLR" GraphId="cd9ef" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="FGFR4" GraphId="d8533" Type="Protein">
        </DataNode>
  <DataNode TextLabel="CYP7A1" GraphId="ef30c" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="De Novo Synthesis&#10;" GraphId="ef470" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="Bile Acid" GraphId="f2aeb" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="f54f0" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ASBT&#10;" GraphId="f9d48" Type="Protein">
    <Comment>"The SLC10A2 (solute carrier family 10 member 2) gene in humans encodes the bile acid:sodium symporter known as the apical sodium&#8211;bile acid transporter (ASBT) or as the ileal bile acid transporter (IBAT)." [https://en.wikipedia.org/wiki/SLC10A2]</Comment>
        </DataNode>
  <DataNode TextLabel="ABCB11" GraphId="fb374" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="ABCG5" GraphId="fed5f" Type="GeneProduct" GroupRef="d61c8">
        </DataNode>
  <DataNode TextLabel="FXR1" GraphId="d30fa" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LDL cholesterol" GraphId="f997b" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="MAPK3" GraphId="c3b3e" Type="GeneProduct" GroupRef="e0e57">
        </DataNode>
  <DataNode TextLabel="FGF19" GraphId="d2720" Type="GeneProduct">
        </DataNode>
  <Interaction GraphId="e4575">
    <Comment>biliary secretion of cholesterol via ABCG5/ABCG8</Comment>
    <Graphics>
      <Point GraphRef="f54f0"/>
      <Point GraphRef="f997b" ArrowHead="Arrow"/>
      <Anchor Position="0.5405669643719568" Shape="None" GraphId="f72d4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id20c4881d">
    <Comment>Transport via portal circulation</Comment>
    <Comment>Basolateral NTCP transports conjugated bile acids into the hepatocytes.</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="a9220"/>
      <Point/>
      <Point GraphRef="f2aeb" ArrowHead="Arrow"/>
      <Anchor Position="0.32001599598349084" Shape="None" GraphId="ca3ba"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id29259dc9">
    <Comment>Bile acids in the hepatocytes activate FXR to inhibit CYP7A1.</Comment>
    <Graphics>
      <Point GraphRef="d30fa"/>
      <Point GraphRef="ef30c" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id32001859">
    <Graphics>
      <Point GraphRef="d8533"/>
      <Point GraphRef="d118a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id39d4d4b1">
    <Comment>Bile acids in the hepatocytes activate FXR to inhibit CYP7A1.</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f2aeb"/>
      <Point GraphRef="d30fa" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4277b65">
    <Comment>First and rate-limiting step in cholesterol conversion into bile acids.</Comment>
    <Graphics LineStyle="Broken">
      <Point GraphRef="f54f0"/>
      <Point GraphRef="f2aeb" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5252241846399399" Shape="None" GraphId="ef914"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4c64cfdb">
    <Graphics>
      <Point GraphRef="fb374"/>
      <Point GraphRef="aba00" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id52bc4826">
    <Comment>Bile acids in the small intestine activate FXR to induce FGF15.</Comment>
    <Graphics>
      <Point GraphRef="a9220"/>
      <Point GraphRef="b8394" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5c4dbb0f">
    <Comment>Ee-absorbtion of bile acids into the enterocytes via ASBT</Comment>
    <Graphics>
      <Point GraphRef="a42f3"/>
      <Point GraphRef="f9d48" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id65b55064">
    <Graphics>
      <Point GraphRef="cd9ef"/>
      <Point GraphRef="fe4ed" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7aee9551">
    <Graphics>
      <Point GraphRef="a1845"/>
      <Point GraphRef="f54f0" ArrowHead="Arrow"/>
      <Anchor Position="0.21759820481636252" Shape="None" GraphId="fe4ed"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id83d6f460">
    <Graphics>
      <Point GraphRef="cbf70"/>
      <Point GraphRef="ca3ba" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id87048896">
    <Graphics>
      <Point GraphRef="ef30c"/>
      <Point GraphRef="ef914" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9075c8dc">
    <Graphics>
      <Point GraphRef="f8ca8"/>
      <Point GraphRef="f72d4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbcdb6027">
    <Comment>Acquiring cholesterol via de novo synthesis</Comment>
    <Graphics>
      <Point GraphRef="ef470"/>
      <Point GraphRef="f54f0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idccdd9e2e">
    <Comment>Bile acids release into the small intestine</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f2aeb"/>
      <Point/>
      <Point GraphRef="a42f3" ArrowHead="Arrow"/>
      <Anchor Position="0.3069302472193454" Shape="None" GraphId="aba00"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd736ccfc">
    <Graphics>
      <Point GraphRef="f9d48"/>
      <Point GraphRef="a9220" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd7ef0789">
    <Comment>Bile acids in the small intestine activate FXR to induce FGF15.</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b8394"/>
      <Point GraphRef="d2720" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide951a67">
    <Comment>FGF15 binds and activates FGFR4</Comment>
    <Graphics>
      <Point GraphRef="d2720"/>
      <Point GraphRef="d8533" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfec0e2d7">
    <Graphics>
      <Point GraphRef="d118a"/>
      <Point GraphRef="ef30c" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Shape TextLabel=" &#10;      &#10;      Hepatocyte" GraphId="fe46a">
    <Graphics Align="Left" ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape TextLabel="Enterocyte" GraphId="b5b68">
    <Graphics Align="Right" ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Group GroupId="e0e57" GraphId="d118a" Style="Group"/>
  <Group GroupId="d61c8" GraphId="f8ca8" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b8e">
      <bp:ID >29653253</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta Mol Cell Biol Lipids</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Wang Y</bp:AUTHORS>
      <bp:AUTHORS >Ding WX</bp:AUTHORS>
      <bp:AUTHORS >Li T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >bile acid biosynthetic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000039</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>